Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by SanFrancisco99on Aug 07, 2014 10:50am
320 Views
Post# 22817479

RE:RE:OK Don and Julie: How About An Update????

RE:RE:OK Don and Julie: How About An Update????Hi Archman:  Thank you for your post.  

If you are correct, then it will be nice to finally get an update on Resverlogix.  Been a long time.

Regarding Zenith, if you are right then that raises another question:  If the oft-rumoured IPO is due in the Fall of 2014 (as has been the latest rumours I heard), then it doesn't make sense to have the next Webcast be in 2 months.  That would mean the Webcast is in early October.  The farther out that Webcast gets pushed, that would mean to me that the IPO is being pushed out again too.  

I heard Zenith IPO rumours last year that indicated an IPO last Winter.  Then it became Spring.  Then Summer.  Now Fall.  Now is it going to be Winter of 2015???

If Zenith's next Webcast is in October, then it would lead me to suspect that Zenith might not be IPO'ing in the Fall after all.  

Another delay between now and a date when the investment is liquid???


Bullboard Posts